PET
0.019
171.4%
STP
0.265
-44.2%
CKA
0.073
69.8%
VBS
0.11
-37.1%
A1G
0.52
65.1%
IPB
0.006
-33.3%
APC
0.015
50%
NAE
0.002
-33.3%
AYT
0.006
50%
SFG
0.002
-33.3%
ERA
0.003
50%
OVT
0.005
-28.6%
RMY
0.045
45.2%
VUL
4.41
-27.5%
TCG
0.75
38.9%
IMI
0.011
-26.7%
QFE
0.081
37.3%
CTN
0.003
-25%
PNN
0.12
36.4%
MAY
0.009
-25%
DAL
0.054
35%
RKB
0.003
-25%
DMG
0.008
33.3%
NFM
0.016
-23.8%
FBR
0.004
33.3%
EPI
1.005
-23.3%
MRQ
0.004
33.3%
IBX
0.02
-23.1%
BDG
0.08
29%
RML
0.053
-22.1%
MGA
0.081
28.6%
AUR
0.018
-21.7%
NES
0.009
28.6%
LMG
0.023
-20.7%
GR8
0.205
28.1%
AKN
0.004
-20%
EDU
0.77
27.3%
FCT
0.008
-20%
PKY
0.019
26.7%
GLL
0.008
-20%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

The Calmer Co. International (ASX:CCO) generates over $150,000 in sales from its kava-based health drinks now available at Coles

ASX:CCO Share Price

The Calmer Co. International (ASX:CCO) has revealed April ecommerce sales have continued to grow strongly, having now surpassed $11,000 per day.

  • Coles scan sales over the initial launch period exceed $150,000 and were running at over $30,000 per week and greater than 4,600 units per week, in week 8 after launch
  • ecommerce sales continue to grow month-on-month and now exceed $11,000 per day

Anthony Noble, CEO of The Calmer Co. International, says: “Excellence in ecommerce is our primary growth pillar. We have continued to grow month-on-month in these channels, with both Shopify and Amazon contributing.”

“The initial sales results for the new range of three products in Coles are extremely promising and this is now backed up by scan data showing a rapid acceleration in both value of retail sales and units sold across the discount cycle in Coles.”